J.Safra Asset Management Corp Buys Shares of 3,447 Astera Labs, Inc. $ALAB

J.Safra Asset Management Corp purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 3,447 shares of the company’s stock, valued at approximately $1,665,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Reflection Asset Management purchased a new position in Astera Labs in the fourth quarter worth $25,000. Smartleaf Asset Management LLC raised its position in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in Astera Labs during the fourth quarter valued at about $33,000. Whipplewood Advisors LLC raised its position in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares in the last quarter. Finally, Assetmark Inc. lifted its stake in Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after purchasing an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $3,276,963.90. Following the completion of the transaction, the director owned 5,292 shares of the company’s stock, valued at approximately $1,928,140.20. This represents a 62.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 940,716 shares of company stock valued at $292,425,777 over the last quarter. 10.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ALAB has been the subject of a number of research reports. JPMorgan Chase & Co. upped their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. TD Cowen dropped their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research report on Wednesday, August 5th. Barclays upped their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Bank of America increased their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Susquehanna lifted their price target on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $325.25.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $321.61 on Monday. The stock has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84. The stock’s 50-day moving average price is $358.00 and its 200-day moving average price is $240.74. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter last year, the business earned $0.44 earnings per share. The business’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.